ARCHIVES

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

Interim Results Show Vaccine Lowers Breast Cancer Recurrence

December 30, 2011

FDA Oncology Division Director Says Goal to Make Review Process “Predictable”

August 2, 1996

Seer Gets Extra $5000,000 to Permit Addition Of One Registry To Braden Coverage Of Blacks, Hispanics

October 22, 1982

Cooperative Groups Pursue Contracts With Insurers, NCI Warns of Competition

June 14, 1996

In Brief

February 7, 2014

Abstracts Of Papers Presented By Breast Cancer Task Force

July 16, 1976